In-licensing and Technical Due Diligence
Venn provides In-licensing and Technical Due Diligence through its wholly owned subsidiary Kinesis Pharma BV.
For pharmaceutical companies that are looking for in-licensing compounds or patents (IP) Venn/Kinesis Pharma BV can perform a technical due diligence. Venn/Kinesis Pharma BV multi-disciplinary experts review the non-clinical, pharmaceutical (CMC), clinical and regulatory information that is available for the in-licensing opportunity. The strengths and weaknesses of the product, the gaps in the development program and the underlying risks will be presented. The due diligence can be completed with an estimate and planning of the studies and resources needed to develop the product.
For pharmaceutical companies that want to out-license their assets Venn/Kinesis Pharma BV can assist to organize the data in such a way that a better negotiation position can be obtained in the out-licensing process.
Johan te Koppele, Ph.D.
Managing Director Kinesis Pharma B.V.
Tel: + 31 76 54 80 671
Mob: +31 6 44 53 86 37